GP
DMK

Grow Partners’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History

Grow Partners’s Portfolio DMK Stock Details DMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-5,437
Closed -$1.78M – 42
2014
Q3 		$1.78M Sell
5,437
-1,780
-25% -$522K 1.6% 20
2014
Q2 		$2.43M Buy
7,217
+2,574
+55% +$1.01M 1.76% 23
2014
Q1 		$2.07M Hold
4,643
– – 1.36% 25
2013
Q4 		$2.08M Buy
+4,643
New +$2.04M 1.27% 23

Other funds holding DMK

SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Grow Partners's DMK Position: Q4 2014 in Review

Grow Partners sold out of DMK Pharmaceuticals Corporation Common Stock (DMK) in Q4 2014, closing a stake of 5,437 shares — an estimated $1.78M sold.

Grow Partners first reported a position in DMK in Q4 2013 and held it in 4 quarters. The position peaked at $2.43M in Q2 2014. 21 funds tracked by Wall St. Rank hold DMK as of Q4 2014.

  • Grow Partners reported no remaining DMK Pharmaceuticals Corporation Common Stock position as of Q4 2014 after selling out during the quarter.
  • Grow Partners sold 5,437 DMK Pharmaceuticals Corporation Common Stock shares in Q4 2014, an estimated $1.78M.
  • Grow Partners first reported a position in DMK Pharmaceuticals Corporation Common Stock in Q4 2013 and held it in 4 quarters.
  • Grow Partners's DMK Pharmaceuticals Corporation Common Stock position peaked at $2.43M in Q2 2014.
  • 21 funds tracked by Wall St. Rank held DMK Pharmaceuticals Corporation Common Stock as of Q4 2014.

Based on Grow Partners's 13F filing for Q4 2014, filed 18 Feb 2015.